[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342200-105":59,"doc-detail-342200-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mettl16-inhibits-pancreatic-cancer-proliferation-and-metastasis-experimental-studies","METTL16 inhibits pancreatic cancer proliferation and metastasis - experimental studies","","N6-methyladenosine (m6A) modification drives cancer progression, yet its mechanism in pancreatic cancer metastasis remains unclear. This study investigates METTL16, an m6A writer, focusing on regulation of core genes CAPN2 and MROH8 to determine effects on tumor growth and dissemination. Transcriptomic TCGA analyses, survival correlations, and functional experiments with METTL16 knockdown/overexpression were combined with organoids and animal models. Immunofluorescence, Co-IP, m6A-qPCR, and ChIP were used to validate RNA modifications and TBP-mediated transcriptional control. Results show METTL16 suppresses growth and metastasis via an METTL16–MROH8–TBP–CAPN2 regulatory axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mettl16-inhibits-pancreatic-cancer-proliferation-and-metastasis-experimental-studies/342200/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mettl16-inhibits-pancreatic-cancer-proliferation-and-metastasis-experimental-studies/342200.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about pancreatic cancer metastasis?","Question",{"text":112,"@type":113},"The study examines how m6A modification affects pancreatic cancer metastasis and specifically clarifies METTL16’s role in regulating CAPN2 and MROH8.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers evaluate METTL16’s function?",{"text":117,"@type":113},"They used transcriptomic TCGA data for gene selection and then performed functional assays with METTL16 knockdown and overexpression in pancreatic cancer cell lines, patient-derived organoids, and animal models.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathway is proposed to explain METTL16’s antitumor effects?",{"text":121,"@type":113},"METTL16 enhances MROH8 mRNA stability through m6A modification, leading to TBP degradation, reduced CAPN2 expression, and ultimately suppression of tumor proliferation and metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342200,1790082446,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","’Experimental Research  \nMETTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression – experimental studies  \nTingzhuang Yi, MDa , Chunming Wang, MDb , Xia Ye, MDc , Jie Lin, MDa , Cheng Lin, MDa , Fengzhen Qin, MDd , Wanlin Yang, MDc , Yulu Ye, MDc , Dengchong Ning, MDc , Jinyan Lan, MDc , Huafu Li, MDe,*, Chunying Luo, MDa,*, Jian Ma, MDf,*, Zhongheng Wei, MDa,*  \nBackground: N6-methyladenosine (m6A) modiﬁcation plays a crucial role in the progression of various cancers, including  pancreatic cancer, by regulating gene expression. However, the speciﬁc mechanisms by which m6A affects pancreatic cancer metastasis remain unclear. This study aims to elucidate the role of METTL16, an m6A writer gene, in regulating core genes such as CAPN2 and MROH8, inﬂuencing tumor growth and metastasis.  \nMaterials and Methods: Transcriptomic data from pancreatic cancer patients in The Cancer Genome Atlas (TCGA) were analyzed to identify m6A-related genes. We performed correlation and survival analyses to uncover core genes inﬂuenced by m6A expression. Functional assays, including METTL16 knockdown and overexpression experiments, were conducted in pancreatic cancer cell lines, patient-derived organoids, and animal models. Immunoﬂuorescence, co-immunoprecipitation (Co-IP), and m6A-speciﬁc quantitative PCR were used to validate protein interactions and m6A modiﬁcations. Chromatin immunoprecipitation (ChIP) analysis was utilized to investigate transcription factor binding at gene promoter regions.  \nResults: METTL16 and METTL3 were identiﬁed as key m6A regulators associated with improved prognosis in pancreatic cancer patients (P \u003C 0.05) . CAPN2, CHMP2B, ITGA3, ITGA6, ITPR1, and RAC1 were identiﬁed as core genes linked to m6A expression, all signiﬁcantly correlated with patient prognosis (P \u003C 0.05) . METTL16 overexpression signiﬁcantly inhibited tumor growth and metastasis (P \u003C 0.001) by downregulating CAPN2 through an indirect mechanism involving the transcription factor TBP and the gene MROH8 . MROH8 negatively regulated CAPN2 by promoting TBP degradation, with METTL16 enhancing MROH8 mRNA stability through m6A modiﬁcations (P \u003C 0.01) . Functional assays demonstrated that METTL16 andYTHDC2 (an m6A reader) collaboratively enhanced MROH8 mRNA stability, thereby inhibiting CAPN2 expression and reducing tumor proliferation and metastasis (P \u003C 0.001) .  \nConclusion: This study reveals a novel regulatory axis involving METTL16, MROH8, and TBP that modulates CAPN2 expression, contributing to the suppression of pancreatic cancer progression. The METTL16–MROH8–TBP–CAPN2 pathway offers potential therapeutic targets for pancreatic cancer treatment, highlighting the signiﬁcance of m6A modiﬁcations in tumor regulation. Further clinical validation is needed to conﬁrm these ﬁndings in human patients.  \nKeyWords: Pancreatic cancer, m6A, METTL16, TBP, MROH8, CAPN2  \naDepartment of Oncology, Afﬁliated Hospital of YouJiang Medical University for Nationalities/Key Laboratory of Molecular Pathology in Tumors of Guangxi Higher Education Institutions, Baise, Guangxi, People’s Republic of China, bDepartment of Hepatopancreatobiliary & Vascular Surgery, The Second Afﬁliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China, cYoujiang Medical University for Nationalities, Baise, Guangxi, People’s Republic of China, dAfﬁliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, People’s Republic of China, eImperial College London, Sir Alexander Fleming Building, South Kensington Campus,  \nLondon, UK and fDepartment of Hepatobiliary Surgery, Jining Public Health Medical Center, Jining, People’s Republic of China Tingzhuang Yi, Chunming Wang, Xia Ye, and Jie Lin contributed equally to this work.  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding authors. Address: Imperial College L","cbCaibf5UVwLeIfN","https://ap.wps.com/l/cbCaibf5UVwLeIfN","pdf",2752901,"English","# Introduction\n# Materials and Methods\n## Functional assays\n## Molecular validation (Co-IP, m6A-qPCR, ChIP)\n# Results\n# Conclusion","[{\"question\":\"What question does the study address about pancreatic cancer metastasis?\",\"answer\":\"The study examines how m6A modification affects pancreatic cancer metastasis and specifically clarifies METTL16’s role in regulating CAPN2 and MROH8.\"},{\"question\":\"How did the researchers evaluate METTL16’s function?\",\"answer\":\"They used transcriptomic TCGA data for gene selection and then performed functional assays with METTL16 knockdown and overexpression in pancreatic cancer cell lines, patient-derived organoids, and animal models.\"},{\"question\":\"What molecular pathway is proposed to explain METTL16’s antitumor effects?\",\"answer\":\"METTL16 enhances MROH8 mRNA stability through m6A modification, leading to TBP degradation, reduced CAPN2 expression, and ultimately suppression of tumor proliferation and metastasis.\"}]","METTL16 inhibits pancreatic cancer proliferation and metastasis - experimental studies | PDF",1790045753,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b58da018f8c2ef217fb618d4f9bdb81c.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ba2ecb2ce2d9187107a5f210e772056.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9edd707b83c358dd634f1ef8c904323a.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc695e7ba2631d96cd9ea4d55adcb8cd.webp",980,1306]